Other PBMs May Settle With FTC On Insulin Suits
The Federal Trade Commission (FTC) may be close to settlement in its insulin suits with CVS Caremark and OptumRx, two of the remaining big 3 pharmacy benefits managers (PBMs). Express Scripts has already settled and any future settlements are expected to be as far-reaching in terms of impacting existing business practices.
The FTC said in a court filing that it is making “significant progress” in talks with the two PBMs,
Additional article: https://www.fiercehealthcare.com/payers/ftc-seeing-progress-discussions-optum-caremark-insulin-case
#pbms #drugpricing #ftc
https://www.healthcaredive.com/news/optumrx-caremark-progress-ftc-settlement-insulin-case/813834
